BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37531206)

  • 1. HBx promotes hepatocellular carcinoma progression by repressing the transcription level of miR-187-5p.
    Deng Y; Wang L; Zhang Y; Sun D; Min H; Zhou H; Xu C; Xu N; Qiu F; Zhou J; Zhou J
    Aging (Albany NY); 2023 Aug; 15(15):7533-7550. PubMed ID: 37531206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA F11-AS1 inhibits HBV-related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA-211-5p.
    Deng Y; Wei Z; Huang M; Xu G; Wei W; Peng B; Nong S; Qin H
    J Cell Mol Med; 2020 Jan; 24(2):1848-1865. PubMed ID: 31880390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells.
    Yu G; Chen X; Chen S; Ye W; Hou K; Liang M
    J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of miR-200a-3p induced by hepatitis B Virus X (HBx) Protein promotes cell proliferation and invasion in HBV-infection-associated hepatocarcinoma.
    Shi T; Hua Q; Ma Z; Lv Q
    Pathol Res Pract; 2017 Dec; 213(12):1464-1469. PubMed ID: 29103765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B virus X protein boosts hepatocellular carcinoma progression by downregulating microRNA-137.
    Gao Y; Gu J; Wang Y; Fu D; Zhang W; Zheng G; Wang X
    Pathol Res Pract; 2020 Jun; 216(6):152981. PubMed ID: 32527447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation.
    Niu LJ; Huang T; Wang L; Sun XF; Zhang YM
    Ann Hepatol; 2022; 27(3):100688. PubMed ID: 35196550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus promotes proliferation and metastasis in male Chinese hepatocellular carcinoma patients through the LEF-1/miR-371a-5p/SRCIN1/pleiotrophin/Slug pathway.
    Bai PS; Hou P; Kong Y
    Exp Cell Res; 2018 Sep; 370(1):174-188. PubMed ID: 29928866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HBx-induced MiR-1269b in NF-κB dependent manner upregulates cell division cycle 40 homolog (CDC40) to promote proliferation and migration in hepatoma cells.
    Kong XX; Lv YR; Shao LP; Nong XY; Zhang GL; Zhang Y; Fan HX; Liu M; Li X; Tang H
    J Transl Med; 2016 Jun; 14(1):189. PubMed ID: 27349221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
    Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
    Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus X protein mutant HBxΔ127 promotes proliferation of hepatoma cells through up-regulating miR-215 targeting PTPRT.
    Liu F; You X; Chi X; Wang T; Ye L; Niu J; Zhang X
    Biochem Biophys Res Commun; 2014 Feb; 444(2):128-34. PubMed ID: 24434140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329.
    Zhang C; Liu P; Zhang C
    J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus X protein promotes proliferation of hepatocellular carcinoma cells by upregulating miR-181b by targeting ING5.
    Xie X; Xu X; Sun C; Yu Z
    Biol Chem; 2018 May; 399(6):611-619. PubMed ID: 29604207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus-regulated growth of liver cancer cells occurs through the microRNA-340-5p-activating transcription factor 7-heat shock protein A member 1B axis.
    Song F; Wei M; Wang J; Liu Y; Guo M; Li X; Luo J; Zhou J; Wang M; Guo D; Chen L; Sun G
    Cancer Sci; 2019 May; 110(5):1633-1643. PubMed ID: 30891870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of microRNA on proliferation caused by mutant HBx in human hepatocytes].
    Fu XY; Tan DM; Hou ZH; Hu ZL; Liu GZ; Ouyang Y; Liu F
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug; 20(8):598-604. PubMed ID: 23207154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3.
    Zhang Q; Song G; Yao L; Liu Y; Liu M; Li S; Tang H
    J Exp Clin Cancer Res; 2018 Jan; 37(1):14. PubMed ID: 29378599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis.
    Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X
    Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p.
    Peng Y; Leng W; Duan S; Hong M
    Biomed Pharmacother; 2019 Aug; 116():109027. PubMed ID: 31174090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.